Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening.

Bonaïti B, Alarcon F, Andrieu N, Bonadona V, Dondon MG, Pennec S, Stoppa-Lyonnet D, Bonaïti-Pellié C, Perdry H.

J Med Genet. 2014 Feb;51(2):114-21. doi: 10.1136/jmedgenet-2013-101674. Epub 2013 Dec 16.

PMID:
24343917
[PubMed - in process]
2.

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

Phillips KA, Milne RL, Rookus MA, Daly MB, Antoniou AC, Peock S, Frost D, Easton DF, Ellis S, Friedlander ML, Buys SS, Andrieu N, Noguès C, Stoppa-Lyonnet D, Bonadona V, Pujol P, McLachlan SA, John EM, Hooning MJ, Seynaeve C, Tollenaar RA, Goldgar DE, Terry MB, Caldes T, Weideman PC, Andrulis IL, Singer CF, Birch K, Simard J, Southey MC, Olsson HL, Jakubowska A, Olah E, Gerdes AM, Foretova L, Hopper JL.

J Clin Oncol. 2013 Sep 1;31(25):3091-9. doi: 10.1200/JCO.2012.47.8313. Epub 2013 Aug 5.

PMID:
23918944
[PubMed - indexed for MEDLINE]
3.

Germline BAP1 mutations predispose to renal cell carcinomas.

Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d'Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manié E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Bressac-de Paillerets B, Stoppa-Lyonnet D, Stern MH.

Am J Hum Genet. 2013 Jun 6;92(6):974-80. doi: 10.1016/j.ajhg.2013.04.012. Epub 2013 May 16.

PMID:
23684012
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Noguès C, Gauthier-Villars M, Lasset C, Fricker JP, Peock S, Frost D, Evans DG, Eeles RA, Paterson J, Manders P, van Asperen CJ, Ausems MG, Meijers-Heijboer H, Thierry-Chef I, Hauptmann M, Goldgar D, Rookus MA, van Leeuwen FE; GENEPSO; EMBRACE; HEBON.

BMJ. 2012 Sep 6;345:e5660. doi: 10.1136/bmj.e5660.

PMID:
22956590
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Lecarpentier J, Noguès C, Mouret-Fourme E, Gauthier-Villars M, Lasset C, Fricker JP, Caron O, Stoppa-Lyonnet D, Berthet P, Faivre L, Bonadona V, Buecher B, Coupier I, Gladieff L, Gesta P, Eisinger F, Frénay M, Luporsi E, Lortholary A, Colas C, Dugast C, Longy M, Pujol P, Tinat J; GENEPSO, Lidereau R, Andrieu N.

Breast Cancer Res. 2012 Jul 3;14(4):R99. doi: 10.1186/bcr3218.

PMID:
22762150
[PubMed - in process]
Free PMC Article
6.

Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer.

Coissieux MM, Tomsic J, Castets M, Hampel H, Tuupanen S, Andrieu N, Comeras I, Drouet Y, Lasset C, Liyanarachchi S, Mazelin L, Puisieux A, Saurin JC, Scoazec JY, Wang Q, Aaltonen L, Tanner SM, de la Chapelle A, Bernet A, Mehlen P.

Gastroenterology. 2011 Dec;141(6):2039-46. doi: 10.1053/j.gastro.2011.08.041. Epub 2011 Sep 3.

PMID:
21893118
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO).

Lecarpentier J, Noguès C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Caron O, Fricker JP, Gladieff L, Faivre L, Sobol H, Gesta P, Frenay M, Luporsi E, Coupier I; GENEPSO, Lidereau R, Andrieu N.

Breast Cancer Res Treat. 2011 Dec;130(3):927-38. doi: 10.1007/s10549-011-1655-3. Epub 2011 Jul 15.

PMID:
21761160
[PubMed - indexed for MEDLINE]
8.

[A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition].

Bonaïti B, Alarcon F, Bonadona V, Pennec S, Andrieu N, Stoppa-Lyonnet D, Perdry H, Bonaïti-Pellié C; Groupe Génétique et Cancer.

Bull Cancer. 2011 Jul;98(7):779-95. doi: 10.1684/bdc.2011.1397. French.

PMID:
21708517
[PubMed - indexed for MEDLINE]
9.

Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Bonaïti B, Bonadona V, Perdry H, Andrieu N, Bonaïti-Pellié C.

Eur J Hum Genet. 2011 Feb;19(2):173-9. doi: 10.1038/ejhg.2010.158. Epub 2010 Oct 6.

PMID:
20924409
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Implications of genetic risk factors in breast cancer: culprit genes and associated malignancies].

Stoppa-Lyonnet D, Buecher B, Houdayer C, de Pauw A, Gauthier-Villars M, de la Rochefordière A, This P, Asselain B, Andrieu N.

Bull Acad Natl Med. 2009 Dec;193(9):2063-83; discussion 2084-5. French.

PMID:
20690207
[PubMed - indexed for MEDLINE]
11.

[Lapeyronie disease's treatment].

Andrieu NF, Kleinclauss F.

Prog Urol. 2009 Dec;19(12):902-6. doi: 10.1016/j.purol.2009.09.018. Epub 2009 Nov 7. French.

PMID:
19963189
[PubMed - indexed for MEDLINE]
12.

[Cancer genetics: estimation of the needs of the population in France for the next ten years].

Bonaïti-Pellié C, Andrieu N, Arveux P, Bonadona V, Buecher B, Delpech M, Jolly D, Julian-Reynier C, Luporsi E, Noguès C, Nowak F, Olschwang S, Orsi F, Pujol P, Saurin JC, Sinilnikova O, Stoppa-Lyonnet D, Thépot F.

Bull Cancer. 2009 Sep;96(9):875-900. doi: 10.1684/bdc.2009.0943. Review. French.

PMID:
19751997
[PubMed - indexed for MEDLINE]
13.

[Estimation of individual breast cancer risk: relevance and limits of risk estimation models].

De Pauw A, Stoppa-Lyonnet D, Andrieu N, Asselain B.

Bull Cancer. 2009 Oct;96(10):979-88. doi: 10.1684/bdc.2009.0928. French.

PMID:
19744918
[PubMed - indexed for MEDLINE]
14.

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.

Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R; EMBRACE, Nogues C, Faivre L, Gesta P; GENEPSO, van Leeuwen FE, Ausems MG, Osorio A; GEO-HEBON, Caldes T, Simard J, Lubinski J, Gerdes AM, Olah E, Fürhauser C, Olsson H, Arver B, Radice P, Easton DF, Goldgar DE.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):601-10. doi: 10.1158/1055-9965.EPI-08-0546. Epub 2009 Feb 3.

PMID:
19190154
[PubMed - indexed for MEDLINE]
Free Article
15.

Flexible Two-Phase studies for rare exposures: Feasibility, planning and efficiency issues of a new variant.

Wild P, Andrieu N, Goldstein AM, Schill W.

Epidemiol Perspect Innov. 2008 Oct 1;5:4. doi: 10.1186/1742-5573-5-4.

PMID:
18828892
[PubMed]
Free PMC Article
16.

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.

Brohet RM, Goldgar DE, Easton DF, Antoniou AC, Andrieu N, Chang-Claude J, Peock S, Eeles RA, Cook M, Chu C, Noguès C, Lasset C, Berthet P, Meijers-Heijboer H, Gerdes AM, Olsson H, Caldes T, van Leeuwen FE, Rookus MA.

J Clin Oncol. 2007 Sep 1;25(25):3831-6. Epub 2007 Jul 16.

PMID:
17635951
[PubMed - indexed for MEDLINE]
17.

Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.

Chang-Claude J, Andrieu N, Rookus M, Brohet R, Antoniou AC, Peock S, Davidson R, Izatt L, Cole T, Noguès C, Luporsi E, Huiart L, Hoogerbrugge N, Van Leeuwen FE, Osorio A, Eyfjord J, Radice P, Goldgar DE, Easton DF; Epidemiological Study of Familial Breast Cancer (EMBRACE); Gene Etude Prospective Sein Ovaire (GENEPSO); Genen Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON); International BRCA1/2 Carrier Cohort Study (IBCCS) collaborators group.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):740-6.

PMID:
17416765
[PubMed - indexed for MEDLINE]
Free Article
18.

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van't Veer L, Van Leeuwen FE, Goldgar DE.

J Clin Oncol. 2006 Jul 20;24(21):3361-6. Epub 2006 Jun 26.

PMID:
16801631
[PubMed - indexed for MEDLINE]
19.

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G, Eccles D, Douglas F, Noguès C, Gauthier-Villars M, Chompret A, Van Leeuwen FE, Kluijt I, Benitez J, Arver B, Olah E, Chang-Claude J; EMBRACE; GENEPSO; GEO-HEBON; IBCCS Collaborators Group.

J Natl Cancer Inst. 2006 Apr 19;98(8):535-44.

PMID:
16622123
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Unconditional analyses can increase efficiency in assessing gene-environment interaction of the case-combined-control design.

Goldstein AM, Dondon MG, Andrieu N.

Int J Epidemiol. 2006 Aug;35(4):1067-73. Epub 2006 Mar 23.

PMID:
16556643
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk